{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "4025217", "DateCompleted": {"Year": "1985", "Month": "09", "Day": "13"}, "DateRevised": {"Year": "2010", "Month": "11", "Day": "18"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0192-415X", "JournalIssue": {"Volume": "13", "Issue": "1-4", "PubDate": {"Year": "1985"}}, "Title": "The American journal of Chinese medicine", "ISOAbbreviation": "Am J Chin Med"}, "ArticleTitle": "The effects of Ba-wei-wan (hachimijiogan) on plasma levels of high density lipoprotein-cholesterol and lipoperoxide in aged individuals.", "Pagination": {"StartPage": "71", "EndPage": "76", "MedlinePgn": "71-6"}, "Abstract": {"AbstractText": ["Ba-wei-wan was administered for 7 months to 24 aged, non-hospitalized subjects. Laboratory examinations showed an improvement in serum or plasma levels of total lipid, LPO and HDL-C. Other blood examinations were shown to be unaffected by the treatment. To reconfirm the effects of Ba-wei-wan on lipid metabolism, the three step administration of the drug was employed. The elevation of HDL-C levels and the decrease of LPO levels were obtained by this treatment. The discontinuation of this drug induced the converse effect on the plasma levels; decreased HDL-C and increased LPO. It could be concluded from these results that Ba-wei-wan administration improved the lipid metabolism in the aged subjects."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Yoshida", "ForeName": "H", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kusukawa", "ForeName": "R", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Watanabe", "ForeName": "N", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ohtsuki", "ForeName": "G", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Sakamoto", "ForeName": "T", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Haranaka", "ForeName": "R", "Initials": "R"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Singapore", "MedlineTA": "Am J Chin Med", "NlmUniqueID": "7901431", "ISSNLinking": "0192-415X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cholesterol, HDL"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypolipidemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipid Peroxides"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipids"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["blood"], "DescriptorName": "Cholesterol, HDL"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Hyperlipidemias"}, {"QualifierName": [], "DescriptorName": "Hypolipidemic Agents"}, {"QualifierName": [], "DescriptorName": "Japan"}, {"QualifierName": ["blood"], "DescriptorName": "Lipid Peroxides"}, {"QualifierName": ["blood"], "DescriptorName": "Lipids"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1985", "Month": "1", "Day": "1"}, {"Year": "1985", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1985", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["4025217", "10.1142/S0192415X85000113", "S0192415X85000113"]}}]}